Skip to main content
. 2020 May 15;9(5):1489. doi: 10.3390/jcm9051489

Table 4.

Pathway-enrichment of blood-based methylome-wide association results.

Pathway Pathway Source GSEA ID Size Count Z-Score p-Value q-Value
Plan 1: All Subjects
Type II diabetes mellitus KEGG M19708 47 14 4.017 2.95E-05 7.35E-03
MHC class II antigen presentation REACTOME M705 91 16 3.557 1.87E-04 2.33E-02
Host Interactions of HIV factors REACTOME M5283 132 11 3.202 6.81E-04 5.65E-02
Lysosome KEGG M11266 121 11 3.111 9.31E-04 5.80E-02
GABA-B receptor activation REACTOME M954 38 10 3.008 1.31E-03 6.54E-02
L1CAM interactions REACTOME M872 86 17 2.987 1.41E-03 6.54E-02
Vascular smooth muscle contraction KEGG M9387 115 22 2.852 2.17E-03 7.73E-02
Plan 2: Only Males
Neurotransmitter receptors and postsynaptic signal transmission REACTOME M752 137 25 3.369 3.77E-04 1.02E-01
Transmission across chemical synapses REACTOME M15514 186 34 3.287 5.06E-04 1.02E-01
GABA receptor activation REACTOME M976 52 11 3.041 1.18E-03 1.06E-01
Phospholipase C-mediated cascade REACTOME M856 54 12 2.754 2.94E-03 1.98E-01
Plan 3: Only Females
GABA-B receptor activation REACTOME M954 38 11 3.698 1.09E-04 2.66E-02
O-linked glycosylation of mucins REACTOME M546 59 10 3.418 3.15E-04 3.86E-02
GABA receptor activation REACTOME M976 52 13 3.364 3.84E-04 3.86E-02
extracellular matrix (ECM) regulators NABA M3468 238 41 3.361 3.88E-04 3.86E-02
Plan 5: Non-hypertensive Subjects
Retinoblastoma 1 pathway PID M279 65 10 3.71 1.04E-04 3.20E-02
Circadian clock REACTOME M938 53 12 3.508 2.26E-04 3.48E-02
Alzheimer’s disease KEGG M16024 169 24 3.011 1.30E-03 1.34E-01

GSEA: Gene Set Enrichment Analysis; Size: number of genes in the pathway; Count: number of enriched genes in the pathway; KEGG: Kyoto Encyclopedia of Genes and Genomes; REACTOME: REACTOME pathway knowledgebase; PID: Pathway Interaction Database; NABA: Matrisome Project. The false discovery rate thresholds were 0.1, 0.2, 0.05, and 0.15 for plans 1, 2, 3, and 5, respectively.